- Nawah Scientific announces the closing of a $23 million funding round led by Life Ventures Capital to support its expansion plans in the deep tech sector.
- The funding round saw participation from a group of investors, including Dean Ventures, Empire M, Afribek Invest, El Sewedy, along with several banks.
Nawah Scientific has announced the closing of a $23 million funding round led by Life Ventures Capital, aimed at supporting the company’s expansion plans in the deep tech sector.
The round was structured as a blended financing package combining equity and debt, with participation from a group of investment funds, banks, and angel investors focused on deep tech and life sciences.
Participating investors included Dean Ventures, Empire M, Afribek Invest, El Sewedy, in addition to several banks and angel investors.
The transaction reflects growing investor confidence in Nawah Scientific’s business model, which is built on specialized scientific research and deep technology.
Dr. Omar Shoukry Saqr, Founder and CEO of Nawah Scientific, said the funding round is intended to support the company’s regional and international expansion plans and to further strengthen its research and technological infrastructure in the coming phase.
He noted that this comes particularly after the company was recently selected among the winning alliances of the presidential initiative “Alliance and Development.”
“The closing of this round confirms the ability of Nawah’s research-driven model to achieve long-term sustainable growth and to transform science into real economic value,” Saqr added.
In the next phase, Nawah Scientific plans to expand its research infrastructure, including the establishment of a global research center in Rwanda, as well as doubling the size of its existing laboratories in Egypt and Saudi Arabia.
These plans are part of a broader strategy aimed at reinforcing Nawah’s position as a regional and international hub for applied scientific research in life sciences, pharmaceuticals, and deep technology.
About Nawah Scientific
Over the past 10 years, Nawah Scientific has invested nearly $7 million in scientific research, supporting innovation across the medical, pharmaceutical, and agricultural sectors.
The organization operates several specialized units, including a life sciences unit focused on cancer research, stem cells, and nanotechnology applications; a pharmaceutical industry services unit; a food and agriculture unit specializing in soil analysis; and a reference materials unit.
Nawah’s research laboratories span a total area of approximately 20,000 square meters, with a current presence in Cairo, Riyadh, the UAE, and Poland, alongside near-term expansion plans in Rwanda and South Africa.
The company is the first African research center to receive accreditation from the US Food and Drug Administration (US-FDA) and has been selected among the YASR30 list of the 30 most promising African startups.
